COMPASS THERAPEUTICS INC (CMPX) Institutional Selling Activity

Several institutional investors tracked by InsiderSet reduced exposure to COMPASS THERAPEUTICS INC (CMPX) during the quarter ended March 31, 2026 based on sequential SEC Form 13F filings.

The largest disclosed institutional seller of CMPX during the latest reporting period reduced its reported position by approximately $509,600 based on quarter-end filing values.

Institutional selling activity may reflect profit-taking, sector rotation, portfolio rebalancing, or changing conviction levels among major investment firms. InsiderSet tracks quarter-over-quarter holding reductions, full exits, estimated value changes, and historical selling activity using publicly disclosed SEC filing data.

The investors covered on this page collectively reduced approximately $801,685.266 in reported CMPX exposure during the latest filing period, although many institutional holders continue to maintain significant long-term ownership positions in COMPASS THERAPEUTICS INC.

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q1 2026Sequoia Financial AdvisorsSell-35915,535$82,181
Q3 2025Renaissance Technologies LLCSell-145,60079,000$276,500
Q3 2025Sequoia Financial AdvisorsSell-73215,753$55,136
Q2 2025Renaissance Technologies LLCSell-96,900224,600$583,960
Q2 2025Sequoia Financial AdvisorsSell-11,44916,485$42,861
Q1 2025Sequoia Financial AdvisorsSell-2,94227,934$53,075
Q1 2024Renaissance Technologies LLCSell-106,39970,400$139
Q3 2023Renaissance Technologies LLCSell-25,50026,800$53
Q4 2022Renaissance Technologies LLCSell-12,31551,900$261
Q3 2022Renaissance Technologies LLCSell-1,95064,215$146

Frequently asked questions about CMPX activity

  • Which institutional owners are buying CMPX?

    Institutional owners buying CMPX include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in CMPX activity?

    "Buy" means an investor increased their reported position in CMPX compared to the prior reporting period. This reflects growing exposure to COMPASS THERAPEUTICS INC (CMPX) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in CMPX increasing?

    Institutional interest in CMPX can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.